Moderna Stock Soars After First US Bird-Flu Death

Category: Finance

Moderna's shares surged over 10% following the first reported bird-flu death in the U.S., as the company develops a vaccine for H5N1. Despite the recent gain, the stock has lost over half its value in the past year.

Keywords: Moderna, H5N1, bird flu

Source: Investopedia

Update At: 1/8/2025

Related Sources